Pfizer

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Pfizer and other ETFs, options, and stocks.

About PFE

Pfizer Inc. is a research-based global biopharmaceutical company, which engages in the discovery, development, manufacture, marketing, sales and distribution of biopharmaceutical products worldwide. The firm works across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases. 

CEO
Albert Bourla
CEOAlbert Bourla
Employees
88,000
Employees88,000
Headquarters
New York, New York
HeadquartersNew York, New York
Founded
1849
Founded1849
Employees
88,000
Employees88,000

PFE Key Statistics

Market cap
162.35B
Market cap162.35B
Price-Earnings ratio
-471.83
Price-Earnings ratio-471.83
Dividend yield
5.76%
Dividend yield5.76%
Average volume
40.60M
Average volume40.60M
High today
$29.04
High today$29.04
Low today
$28.51
Low today$28.51
Open price
$28.90
Open price$28.90
Volume
26.11M
Volume26.11M
52 Week high
$40.37
52 Week high$40.37
52 Week low
$25.20
52 Week low$25.20

PFE News

Yahoo Finance 19h
Billionaires Are Buying These High-Yield Dividend Stocks Left and Right. Should You Follow Their Lead? - Yahoo Finance

Are you famous enough for picking great stocks to become a billionaire money manager? If not, then there's a lot you could learn from the handful of folks who h...

Billionaires Are Buying These High-Yield Dividend Stocks Left and Right. Should You Follow Their Lead? - Yahoo Finance
Seeking Alpha 1d
Novo Nordisk, J&J lead R&D rankings in big pharma: report

Weight loss drugmaker Novo Nordisk (NVO) and U.S. healthcare giant Johnson & Johnson (NYSE:JNJ) have become the most transformative companies in big pharma, acc...

Novo Nordisk, J&J lead R&D rankings in big pharma: report
Yahoo Finance 2d
European Patent Office Sides with Moderna In COVID-19 Vaccine Patent Dispute With Pfizer/BioNTech - Yahoo Finance

European Patent Office Sides with Moderna In COVID-19 Vaccine Patent Dispute With Pfizer/BioNTech Moderna Inc (NASDAQ:MRNA) has reportedly achieved a significa...

European Patent Office Sides with Moderna In COVID-19 Vaccine Patent Dispute With Pfizer/BioNTech - Yahoo Finance

Analyst ratings

59%

of 27 ratings
Buy
40.7%
Hold
59.3%
Sell
0%

More PFE News

Seeking Alpha 3d
Moderna vaccine patent upheld by European Patent Office: report

The European Patent Office has reportedly upheld the validity of Moderna’s (NASDAQ:MRNA) 949 patent for its COVID-19 vaccine in an ongoing dispute between the c...

Moderna vaccine patent upheld by European Patent Office: report
Yahoo Finance 3d
Pfizer Inc. Is a Trending Stock: Facts to Know Before Betting on It - Yahoo Finance

Pfizer (PFE) has recently been on Zacks.com's list of the most searched stocks. Therefore, you might want to consider some of the key factors that could influen...

Pfizer Inc. Is a Trending Stock: Facts to Know Before Betting on It - Yahoo Finance
Benzinga 4d
Pfizer, AstraZeneca, Sanofi And Mainz Biomed To Uplevel Europe's Pharma Game - Pfizer - Benzinga

Loading... Loading... On Sunday, Pfizer PFE and AstraZeneca Plc AZN were among the pharmaceutical companies who announced they will be investing a total of nea...

Pfizer, AstraZeneca, Sanofi And Mainz Biomed To Uplevel Europe's Pharma Game - Pfizer - Benzinga
Yahoo Finance 4d
Arvinas and Pfizer Announce Updated Clinical Data from Phase 1b Trial of Vepdegestrant in Combination with ... - Yahoo Finance

Arvinas Inc. – After six months of additional follow-up, clinical benefit rate (63%), overall response rate (41.9%), median progression-free survival (11.2 mon...

Arvinas and Pfizer Announce Updated Clinical Data from Phase 1b Trial of Vepdegestrant in Combination with ... - Yahoo Finance
Seeking Alpha 4d
Pfizer agrees to pay up to $250M to settle Zantac cancer lawsuits - report

Pfizer (NYSE:PFE) will pay up to $250M to settle more than 10,000 U.S. lawsuits alleging that the company concealed cancer risks associated with its now-discont...

Pfizer agrees to pay up to $250M to settle Zantac cancer lawsuits - report
Benzinga 4d
Pfizer Settles Zantac Lawsuits, Agrees To $250M Settlement To Reduce Liability: Report

Loading... Loading... In a bid to settle thousands of lawsuits over its discontinued heartburn drug Zantac, Pfizer Inc. PFE has agreed to pay up to $250 millio...

Pfizer Settles Zantac Lawsuits, Agrees To $250M Settlement To Reduce Liability: Report
Benzinga 5d
Pfizer, Freeport-McMoRan, Vertex Pharmaceuticals And A Major Tech Stock On CNBC's 'Final Trades'

Loading... Loading... On CNBC's “Halftime Report Final Trades,” Joshua Brown of Ritholtz Wealth Management said under $30, Pfizer Inc. PFE is a gift. Pfizer i...

Pfizer, Freeport-McMoRan, Vertex Pharmaceuticals And A Major Tech Stock On CNBC's 'Final Trades'
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.